Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross and Blue Shield of Michigan Cardiovascular Consortium October 1, 2017 Journal of Invasive Cardiology
The Comparative safety of Abciximab versus Eptifibatide in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) August 1, 2017 Journal of Interventional Cardiology
Public Reporting and Case Selection for Percutaneous Coronary Interventions: An Analysis from Two Large Multicenter PCI Databases June 7, 2005 Journal of American College of Cardiology
Relationship Between Operator Volume and Adverse Outcome In Contemporary Percutaneous Coronary Intervention Practice: An Analysis of a Quality Controlled Multicenter Percutaneous Coronary Intervention Clinical Database August 16, 2005 Journal of American College of Cardiology
Renal function based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions August 23, 2011 Journal of American College of Cardiology
Eroding the denominator: the incomplete story of Door-to-Balloon Time Reporting. Research Letter August 21, 2012 Journal of American College of Cardiology
The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) October 1, 2010 Journal Invasive Cardiology
Development of a Multi-Center Interventional Cardiology Database: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Experience October 1, 2002 Journal Interventional Cardiology
The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Collaborative Quality Improvement Initiative in Percutaneous Coronary Interventions October 15, 2002 Journal Interventional Cardiology
Temporal Trends, Safety, and Efficacy of Bivalirudin in Elective Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular JouConsortium June 1, 2007 Journal Interventional Cardiology